They called it the “biggest sale of the year.”
Three days before US Food and Drug Administration officials told ByHeart on Nov. 7 it was investigating botulism cases in babies that had been given the company’s infant formula, it was promoting an early Black Friday sale. When ByHeart heard from health officials, it issued a limited recall, which expanded into a full recall less than a week later. The formula maker has now confirmed the presence of spores in its cans and is warning all its products could be contaminated.
ByHeart markets itself as a clean alternative to mass-market formula, saying ...
